Junjie
Ying
a,
Jingrong
Huang
a,
Chenguang
Liu
a,
Fa-Jie
Chen
*a,
Chunfa
Xu
*ab and
Fen-Er
Chen
*acd
aInstitute of Pharmaceutical Science and Technology, College of Chemistry, Fuzhou University, Fuzhou, 350108, P. R. China. E-mail: fajie.chen@fzu.edu.cn
bKey Laboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, P. R. China. E-mail: xucf@fzu.edu.cn
cEngineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, 220 Handan Road, Shanghai, 200433, P. R. China. E-mail: rfchen@fudan.edu.cn
dShanghai Engineering Research Center of Industrial Asymmetric Catalysis of Chiral Drugs, Fudan University, 220 Handan Road, Shanghai, 200433, P. R. China
First published on 8th April 2024
Correction for ‘Cu-catalyzed arylation of S-tosyl peptides with arylboronic acids’ by Junjie Ying et al., Org. Chem. Front., 2024, 11, 53–59, https://doi.org/10.1039/D3QO01534C.
The corrected acknowledgements section is shown below:
Acknowledgements
Financial support from the National Natural Science Foundation of China (No. 22201041) and Fuzhou University (No. 511041 and 511264) is acknowledged.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © the Partner Organisations 2024 |